• 2025
  Dejoux A, Zhu Q, Woolfe A, Godon O, Ellouze S, Mottet G, Castrillon C, Gillis C, Pecalvel C, Ganneau C, Iannascoli B, Lemoine F, Saul F, England P, Reber LL, Gouel-Chéron A, de Chaisemartin L, Haouz A, Millot GA, Bay S, Gérard A, Jönsson F, Chollet-Martin S, Bruhns P, Antibody-secreting cell repertoires hold high-affinity anti-rocuronium specificities that can induce anaphylaxis in vivo., J Allergy Clin Immunol 2025 Jan; (): .
• 2025
  Grossi V, Cuny P, Militon C, Witwinowski J, Eddhif B, Sylvi L, Nowakowski M, Kosta A, Antheaume I, Cornil J, Dubrac S, Kende J, Gribaldo S, Borrel G, Halophilic archaea produce wax esters and use an alternative fatty acyl-coenzyme A reductase for precursor synthesis, ISME J 2025 Jan; 19(1): .
• 2024
  Dejoux A, Zhu Q, Ganneau C, Goff OR, Godon O, Lemaitre J, Relouzat F, Huetz F, Sokal A, Vandenberghe A, Pecalvel C, Hunault L, Derenne T, Gillis CM, Iannascoli B, Wang Y, Rose T, Mertens C, Nicaise-Roland P, , England P, Mahévas M, de Chaisemartin L, Le Grand R, Letscher H, Saul F, Pissis C, Haouz A, Reber LL, Chappert P, Jönsson F, Ebo DG, Millot GA, Bay S, Chollet-Martin S, Gouel-Chéron A, Bruhns P, Rocuronium-specific antibodies drive perioperative anaphylaxis but can also function as reversal agents in preclinical models., Sci Transl Med 2024 Sep; 16(764): eado4463.
• 2024
  Brunet J, Choucha Z, Gransagne M, Tabbal H, Ku M-W, Buchrieser J, Fernandes P, Batalie D, Lopez J, Ma L, Dufour E, Simon E, Hardy D, Petres S, Guinet F, Strick-Marchand H, Monot M, Charneau P, Majlessi L, Duprex WP, Gerke C, Martin A, Escriou N, A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model., J Virol 2024 Apr; (): e0169323.
• 2024
  Hunault L, England P, Barbut F, Iannascoli B, Godon O, Déjardin F, Thomas C, Dupuy B, Guo C, Macdonald L, Gorochov G, Sterlin D, Bruhns P, A monoclonal antibody collection for C. difficile typing ?, Gut Pathog 2024 Jan; 16(1): 4.
• 2024
  Melki J, Kouadio TN, Nowakowski M, Razafiarimanga Z, Soumahoro MK, Peltres S, Jambou R, Production and evaluation of a new set of recombinant antigens for the serological diagnosis of human cysticercosis., Exp Parasitol 2024 ; 263-264(): 108803.
• 2023
  Koffi KE, Soumahoro MK, N'Dri KB, Nowakowski M, Guédé CM, Boka OM, Melki J, Touré OA, Djaman J, Bellalou J, N'Goran KE, Jambou R, Seroprevalence of porcine cysticercosis in traditional farms in South-Eastern Côte d’Ivoire., Parasite Epidemiol Control 2023 Aug; 22(): e00311.
• 2023
  Chaouki Benabdessalem, Wafa Ben Hamoudaa, Soumaya Marzoukia, Rokhaya Faye, Adji Astou Mbow, Babacar Diouf, Oumar Ndiaye, Ndongo Dia, Ousmane Faye, Amadou A. Sall, Cheikh Tidiane Diagne, Houda Amellal, Sayeh Ezzikouri, Diary Juliannie Ny Mioramalala, Fanirisoa Randrianarisaona, Khaled Trabelsi, Mohamed Boumaiza, Sonia Ben Hamouda, Rym Ouni, Soumaya Bchiri, Amani Chaaban, Mariem Gdoura, Yousr Gorgi, Imen Sfar, Sadok Yalaoui, Jalila Ben Khelil, Agnes Hamzaoui, Meya Abdallah, Yosra Cherif, Stephane Petres, Chris Ka Pun Mok, Nicolas Escriou, Sebastien Quesney, Koussay Dellagim, Matthieu Schoenhals, M’hammed Sarih, Ines Vigan-Womas, Jihene Bettaieb, Samia Rourou, Mohamed Ridha Barbouche, Melika Ben Ahmed, Development and comparative evaluation of SARS-CoV-2 S-RBD and N based ELISA tests in various African endemic settings, Diagn Microbiol Infect Dis . 2023 Apr;105(4):115903. .
• 2022
  Benfrid S, Park KH, Dellarole M, Voss JE, Tamietti C, Pehau-Arnaudet G, Raynal B, Brûlé S, England P, Zhang X, Mikhailova A, Hasan M, Ungeheuer MN, Petres S, Biering SB, Harris E, Sakuntabhai A, Buchy P, Duong V, Dussart P, Coulibaly F, Bontems F, Rey FA, Flamand M, , Dengue virus NS1 protein conveys pro-inflammatory signals by docking onto high-density lipoproteins., EMBO Rep 2022 May; (): e53600.
• 2022
  Gransagne M, Aymé G, Brier S, Chauveau-Le Friec G, Meriaux V, Nowakowski M, Dejardin F, Levallois S, Dias de Melo G, Donati F, Prot M, Brûlé S, Raynal B, Bellalou J, Goncalves P, Montagutelli X, Di Santo JP, Lazarini F, England P, Petres S, Escriou N, Lafaye P, , Development of a highly specific and sensitive VHH-based sandwich immunoassay for the detection of the SARS-CoV-2 nucleoprotein., J Biol Chem 2022 Jan; 298(1): 101290.
• 2021
  Crescenzo-Chaigne B, Behillil S, Enouf V, Escriou N, Petres S, Ungeheuer MN, Ghosn J, Tubiana S, Bouadma L, van der Werf S, Demeret C, , , Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA responses in COVID-19 patients., J Clin Virol Plus 2021 Dec; 1(4): 100041.
• 2021
  Pelleau S, Woudenberg T, Rosado J, Donnadieu F, Garcia L, Obadia T, Gardais S, Elgharbawy Y, Velay A, Gonzalez M, Nizou JY, Khelil N, Zannis K, Cockram C, Merkling SH, Meola A, Kerneis S, Terrier B, de Seze J, Planas D, Schwartz O, Dejardin F, Petres S, von Platen C, Pellerin SF, Arowas L, de Facci LP, Duffy D, Cheallaigh CN, Dunne J, Conlon N, Townsend L, Duong V, Auerswald H, Pinaud L, Tondeur L, Backovic M, Hoen B, Fontanet A, Mueller I, Fafi-Kremer S, Bruel T, White M, Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection., J Infect Dis 2021 Nov; 224(9): 1489-1499.
• 2021
  Soumahoro MK, Melki J, Assi B, Kangah YL, Camara M, Tazemda-Kuitsouc GB, Nowakowski M, Yapo-Ehounoud C, Sonan T, Bellalou J, Jambou R, , Seroprevalence of Cysticercosis among Epileptic Patients Attending Neurological Units in the Urban Area of Abidjan., Microorganisms 2021 Aug; 9(8): .
• 2021
  Lavigne M, Helynck O, Rigolet P, Boudria-Souilah R, Nowakowski M, Baron B, Brülé S, Hoos S, Raynal B, Guittat L, Beauvineau C, Petres S, Granzhan A, Guillon J, Pratviel G, Teulade-Fichou MP, England P, Mergny JL, Munier-Lehmann H, SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction., Nucleic Acids Res 2021 Jul; 49(13): 7695-7712.
• 2021
  Le Vu S, Jones G, Anna F, Rose T, Richard JB, Bernard-Stoecklin S, Goyard S, Demeret C, Helynck O, Escriou N, Gransagne M, Petres S, Robin C, Monnet V, Perrin de Facci L, Ungeheuer MN, Léon L, Guillois Y, Filleul L, Charneau P, Lévy-Bruhl D, van der Werf S, Noel H, , Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance., Nat Commun 2021 05; 12(1): 3025.
• 2021
  Rosado J, Pelleau S, Cockram C, Merkling SH, Nekkab N, Demeret C, Meola A, Kerneis S, Terrier B, Fafi-Kremer S, de Seze J, Bruel T, Dejardin F, Petres S, Longley R, Fontanet A, Backovic M, Mueller I, White MT, , Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study., Lancet Microbe 2021 Feb; 2(2): e60-e69.
• 2021
  Anna F, Goyard S, Lalanne AI, Nevo F, Gransagne M, Souque P, Louis D, Gillon V, Turbiez I, Bidard FC, Gobillion A, Savignoni A, Guillot-Delost M, Dejardin F, Dufour E, Petres S, Richard-Le Goff O, Choucha Z, Helynck O, Janin YL, Escriou N, Charneau P, Perez F, Rose T, Lantz O, , High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris., Eur J Immunol 2021 01; 51(1): 180-190.
• 2020
  Grzelak L, Temmam S, Planchais C, Demeret C, Tondeur L, Huon C, Guivel-Benhassine F, Staropoli I, Chazal M, Dufloo J, Planas D, Buchrieser J, Rajah MM, Robinot R, Porrot F, Albert M, Chen KY, Crescenzo-Chaigne B, Donati F, Anna F, Souque P, Gransagne M, Bellalou J, Nowakowski M, Backovic M, Bouadma L, Le Fevre L, Le Hingrat Q, Descamps D, Pourbaix A, Laouénan C, Ghosn J, Yazdanpanah Y, Besombes C, Jolly N, Pellerin-Fernandes S, Cheny O, Ungeheuer MN, Mellon G, Morel P, Rolland S, Rey FA, Behillil S, Enouf V, Lemaitre A, Créach MA, Petres S, Escriou N, Charneau P, Fontanet A, Hoen B, Bruel T, Eloit M, Mouquet H, Schwartz O, van der Werf S, A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations., Sci Transl Med 2020 Sep; 12(559): .
• 2020
  Ku MW, Anna F, Souque P, Petres S, Prot M, Simon-Loriere E, Charneau P, Bourgine M, , A Single Dose of NILV-Based Vaccine Provides Rapid and Durable Protection against Zika Virus., Mol Ther 2020 08; 28(8): 1772-1782.
• 2020
  Rabemananjara HA, Raharinosy V, Razafimahefa RM, Ravalohery JP, Rafisandratantsoa JT, Andriamandimby SF, Rajerison M, Rahelinirina S, Harimanana A, Irinantenaina J, Olive MM, Rogier C, Tordo N, Ulrich RG, Reynes JM, Petres S, Heraud JM, Telfer S, Filippone C, Human Exposure to Hantaviruses Associated with Rodents of the Murinae Subfamily, Madagascar, Emerging Infect. Dis. 2020 Mar;26(3):587-590.
• 2019
  Demarta-Gatsi C, Rivkin A, Di Bartolo V, Peronet R, Ding S, Commere PH, Guillonneau F, Bellalou J, Brûlé S, Abou Karam P, Cohen SR, Lagache T, Janse CJ, Regev-Rudzki N, Mécheri S, Histamine releasing factor and elongation factor 1 alpha secreted via malaria parasites extracellular vesicles promote immune evasion by inhibiting specific T cell responses., Cell Microbiol 2019 Jul; 21(7): e13021.
• 2019
  Maria Sebastian, Sonia Arilla-Luna, Jacques Bellalou, Inmaculada Yruela, Milagros Medina, The Biosynthesis of Flavin Cofactors in Listeria monocytogenes, M. Sebastián, S. Arilla-Luna, J. Bellalou, et al., The Biosynthesis of Flavin Cofactors in Listeria monocytogenes, Journal of Molecular Biology.
• 2018
  Cording S, Medvedovic J, Lécuyer E, Aychek T, Déjardin F, Eberl G, , Mouse models for the study of fate and function of innate lymphoid cells., Eur J Immunol 2018 08; 48(8): 1271-1280.